Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02038023 · ClinicalTrials.gov registry record · Phase 2
Intravaneous Iron(1000 mg Low Molecular Weight Iron Dextran Over 60 Minutes) for Pregnant Women
A Phase 2 study of Pregnancy, sponsored by Auerbach Hematology Oncology Associates P C.
- Completed
- Registry status
- Phase 2
- Development phase
- 74
- Enrollment target
- 1
- Study location
NCT02038023: Completed Phase 2 study of Pregnancy, sponsored by Auerbach Hematology Oncology Associates P C.
NCT02038023 is a Phase 2 study of Pregnancy that has completed, run by Auerbach Hematology Oncology Associates P C. The registered enrollment target is 74 participants, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02038023, a Phase 2 study of Pregnancy, has completed, sponsored by Auerbach Hematology Oncology Associates P C.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 74 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine the percentage of women who achieve anemia correction after a single dose of 1000mg of low molecular weight iron dextran(infed).
Conditions Studied
Interventions
- DRUG Intravaneous iron(low molecular weight iron dextran)
Study Locations (1)
Maryland
- Auerbach Hematology Oncology Assoc - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2013-07 |
| Est. Completion | 2015-08 |
| Phase | Phase 2 |
What the finished NCT02038023 record still lists
NCT02038023 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 74 participants, a relatively small participant target, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which Intravaneous iron(low molecular weight iron dextran) is the first listed.
NCT02038023 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT02038023 about?
NCT02038023 is a clinical study titled "Intravaneous Iron(1000 mg Low Molecular Weight Iron Dextran Over 60 Minutes) for Pregnant Women". To determine the percentage of women who achieve anemia correction after a single dose of 1000mg of low molecular weight iron dextran(infed).
What is the current status of trial NCT02038023?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 74 participants. The study started on 2013-07. Estimated completion is 2015-08.
What conditions does trial NCT02038023 study?
This clinical trial studies the following conditions: Pregnancy.
What interventions are being tested in trial NCT02038023?
The interventions under investigation include: Intravaneous iron(low molecular weight iron dextran) (DRUG).
Who is sponsoring clinical trial NCT02038023?
This trial is sponsored by Auerbach Hematology Oncology Associates P C, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02038023 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02038023's enrollment target sits among peer trials
74 132nd of 191 higher than 60 of 191 other Pregnancy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Progesterone to Enhance the Efficacy and Success of Expectantly Managed Preterm Severe/Superimposed Preeclampsia
RECRUITING · Phase 2
-
Study of Pharmacology of 17-OHPC in Pregnancy
COMPLETED · Phase 2
-
Healthy4Baby: Preventing Postpartum Weight Retention Among Low-Income, Black Women
COMPLETED · Phase 2
-
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
RECRUITING
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Healthy Start: Exploring the Fuel-mediated Programming of Neonatal Growth
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422731 · 74 participants · Early Phase 1
Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy
- NCT03804853 · 74 participants · NA
Rehabilitation Following Reverse Total Shoulder Arthroplasty
- NCT04065776 · 74 participants · NA
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
- NCT04771156 · 74 participants · Phase 4
Ketorolac in Palatoplasty
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia